- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bret Jackson Suggests Drivers of Michigan's Low Hospital Prices
The unique market dynamics in Michigan have contributed to lower hospital prices, but it remains to be seen if recent policy changes will reveal these prices to be artificially depressed, according to Bret Jackson, president of the Economic Alliance for Michigan.
The unique market dynamics in Michigan have contributed to lower hospital prices, but it remains to be seen if recent policy changes will reveal these prices to be artificially depressed, according to Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
In the RAND study comparing hospital prices for privately insured patients to a Medicare benchmark, Michigan’s prices were among the lowest of the states studied and they actually fell during the study timeframe. To what do you attribute that success?
So there’s a number of market dynamics in Michigan that I think contributed to our lower prices. We have a relatively dominant carrier in Michigan, the Blue Cross Blue Shield of Michigan plan, we have Medicaid expansion, certificate of need, we have a relatively low uninsured rate, and so I think all of these things contributed to low prices.
But at the same time, the Michigan legislature just changed the auto no-fault insurance law. The auto insurance companies had been paying charges on an unlimited benefit for a period of time, and that may artificially depress prices. So now that the change is made just a month or so ago, we can see if prices were artificially low and if those prices will change as hospitals try to recoup revenue lost from the auto insurance change.
AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting
July 28th 2025The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD
July 25th 2025A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).
Read More
